BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 25863222)

  • 1. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
    Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
    J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
    Wu J; Zhao J; Zhang B; Qian Y; Gao H; Yu Y; Wei Y; Yang Z; Jiang X; Pang Z
    Int J Nanomedicine; 2014; 9():5261-71. PubMed ID: 25419130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
    Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
    Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
    Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
    Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma.
    Chung EJ; Cheng Y; Morshed R; Nord K; Han Y; Wegscheid ML; Auffinger B; Wainwright DA; Lesniak MS; Tirrell MV
    Biomaterials; 2014 Jan; 35(4):1249-56. PubMed ID: 24211079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma and microenvironment dual targeted nanocarrier for improved antiglioblastoma efficacy.
    Wang X; Zhang Q; Lv L; Fu J; Jiang Y; Xin H; Yao Q
    Drug Deliv; 2017 Nov; 24(1):1401-1409. PubMed ID: 28933201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
    Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
    Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Metalloproteinase- and pH-Sensitive Nanoparticle System Enhances Drug Retention and Penetration in Glioblastoma.
    Dosta P; Dion MZ; Prado M; Hurtado P; Riojas-Javelly CJ; Cryer AM; Soria Y; Andrews Interiano N; Muñoz-Taboada G; Artzi N
    ACS Nano; 2024 Jun; 18(22):14145-14160. PubMed ID: 38761153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein-biomimetic nanocarriers for glioblastoma-targeting delivery: the effect of shape.
    Huang JL; Jiang G; Song QX; Gu X; Song HH; Wang XL; Jiang D; Kang T; Feng XY; Jiang XG; Chen HZ; Gao XL
    Pharmazie; 2016 Dec; 71(12):709-714. PubMed ID: 29441999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment.
    Hu G; Zhang H; Zhang L; Ruan S; He Q; Gao H
    Int J Pharm; 2015 Dec; 496(2):1057-68. PubMed ID: 26598487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
    Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
    Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
    Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC
    Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
    Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
    Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
    Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J
    Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.
    Zhang F; Mastorakos P; Mishra MK; Mangraviti A; Hwang L; Zhou J; Hanes J; Brem H; Olivi A; Tyler B; Kannan RM
    Biomaterials; 2015 Jun; 52():507-16. PubMed ID: 25818456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
    Gutkin A; Cohen ZR; Peer D
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles.
    Huang Z; Song Y; Pang Z; Zhang B; Yang H; Shi H; Chen J; Gong H; Qian J; Ge J
    Int J Nanomedicine; 2017; 12():3023-3036. PubMed ID: 28442910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine-Glycine-Aspartic Acid-Modified Lipid-Polymer Hybrid Nanoparticles for Docetaxel Delivery in Glioblastoma Multiforme.
    Shi K; Zhou J; Zhang Q; Gao H; Liu Y; Zong T; He Q
    J Biomed Nanotechnol; 2015 Mar; 11(3):382-91. PubMed ID: 26307822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model.
    Juthani R; Madajewski B; Yoo B; Zhang L; Chen PM; Chen F; Turker MZ; Ma K; Overholtzer M; Longo VA; Carlin S; Aragon-Sanabria V; Huse J; Gonen M; Zanzonico P; Rudin CM; Wiesner U; Bradbury MS; Brennan CW
    Clin Cancer Res; 2020 Jan; 26(1):147-158. PubMed ID: 31515460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.